Clinical Trial Update: PURETHAL Grasses Rush Study [Phase 4]

View source ↗

Summary

Phase 4 trial update for HAL Allergy's PURETHAL Grasses Rush immunotherapy in allergic rhinitis and allergic rhinoconjunctivitis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Allergic Rhinoconjunctivitis

Drugs mentioned

• PURETHAL Grasses Rush

Snippet

Sponsor: HAL Allergy | Conditions: Allergic Rhinitis, Allergic Rhinoconjunctivitis | Phase 4 | Status: COMPLETED